---
title: "Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285712314.md"
description: "Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock News"
datetime: "2026-05-08T03:05:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285712314.md)
  - [en](https://longbridge.com/en/news/285712314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285712314.md)
generator: "portal-rs"
---

# Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock News

Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock News

### Related Stocks

- [KPRX.US](https://longbridge.com/en/quote/KPRX.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Kiora Pharmaceuticals: Global KIO-301 Partnerships and Advancing ABACUS-2 Study Support Buy Rating with Unchanged $12 Price Target](https://longbridge.com/en/news/296635508.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [U.S. kindergarten vaccine coverage falls, CDC says](https://longbridge.com/en/news/296136711.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**